Recently, Kossel Medtech (Suzhou) Co., Ltd. (hereinafter referred to as Kossel Medtech) successfully completed a financing of over 100 million yuan. This round of financing was led by MING BIOVENTURES and IN CAPITAL.

This round of financing will help Kossel Medtech to enrich its peripheral product pipeline, build a one-stop treatment product system in the peripheral intervention field, expand its production base, and attract more and better high-end talents.

Kossel Medtech was established in November 2013, located in Suzhou. It is a platform company with all-round production and research and development capabilities of vascular interventional devices, and is committed to providing clinical system solutions, with nearly 10,000 square meters of R&D and production bases, professional R&D and testing laboratories, systematic independent innovation R&D capabilities and leading manufacturing capabilities and nearly a hundred knowledge property. It is a platform enterprise with comprehensive production and research and development capabilities of vascular interventional devices, like PTCA balloon dilatation catheter and PTA balloon catheter.